- Top Distributor Lists
- Market Research
- Free E-Newsletter
McKesson Corp. (NYSE: MCK), San Francisco, CA, reported sales for the second quarter ended Sept. 30, 2012, were $29.9 billion, down 1 percent from the same period a year ago. Profit grew 35 percent to $401 million.
Download a Free Chapter:
The Little Black Book of Strategic Planning for Distributors
Submit your email address below to receive a chapter of Brent Grover's new book. When you submit your email you will be signed up to receive weekly distribution news updates.
For the first half of the fiscal year, sales were $60.6 billion, up 1 percent year-over-year. Profit increased 34 percent to $781 million.
Distribution Solutions revenues were down 1 percent in the second quarter, driven mainly by a 1 percent decline in U.S. pharmaceutical distribution revenues, reflecting brand-to-generic conversions and one fewer sales day.
Canadian revenues, on a constant currency basis, decreased 3 percent for the second quarter. Including the unfavorable currency impact of 2 percent, Canadian revenues decreased 5 percent for the second quarter.
Medical-Surgical distribution and services revenues were flat for the quarter, due to the impact of five fewer sales days.
Technology Solutions revenues were flat for the second quarter.